Statements (56)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:healthcare_organization
|
gptkbp:bfsLayer |
4
|
gptkbp:bfsParent |
gptkb:Dixie_Carter
|
gptkbp:affects |
endometrium
|
gptkbp:age |
postmenopausal women
women over 60 |
gptkbp:current_use |
gptkb:Lynch_syndrome
polycystic ovary syndrome |
gptkbp:end_of_life |
approximately 17% for distant cases
approximately 81% for localized cases |
gptkbp:events |
may include imaging tests
important for monitoring recurrence regular check-ups recommended |
gptkbp:genetic_diversity |
gptkb:physicist
gptkb:PTEN_mutation p53 mutation |
https://www.w3.org/2000/01/rdf-schema#label |
Endometrial cancer
|
gptkbp:is_protected_by |
maintaining a healthy weight
managing diabetes regular gynecological exams |
gptkbp:number_of_stages |
Stage I
Stage II Stage III Stage IV |
gptkbp:occurs_in |
most common gynecological cancer in developed countries
rising incidence in recent years |
gptkbp:personal_life |
alcohol consumption may influence risk
diet high in fruits and vegetables may reduce risk physical activity may reduce risk smoking may increase risk |
gptkbp:provides_information_on |
ASCO guidelines available
NCCN guidelines available |
gptkbp:research_focus |
gptkb:vaccine
biomarkers for early detection genetic profiling for personalized treatment |
gptkbp:risk_factor |
gptkb:Company
hormone replacement therapy obesity age over 50 |
gptkbp:scholarships |
counseling services available
educational resources available support groups available |
gptkbp:screenings |
no standard screening test
transvaginal ultrasound for high-risk women |
gptkbp:social_responsibility |
ultrasound
biopsy depends on stage early detection improves survival |
gptkbp:symptoms |
pelvic pain
abnormal vaginal bleeding |
gptkbp:treatment |
gptkb:hospital
radiation therapy chemotherapy hormonal therapy clinical trials available targeted therapy under investigation |